EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real‐Time Tracking of ASCT2‐Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe

Bing-Jun Zhou, Ji-Lei Zhao, Fan Yin, Wen-Da Chen, Yi Sun, Ying-Ying Ren, Yi-Min Chen, Tian Xie, Chong Duan, Jian-Liang Zhou

Advanced Science · 2025

DOI: 10.1002/advs.202507057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Bing-Jun Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou, China. Hauptthemen laut MEDLINE: Glutamine, Amino Acid Transport System ASC, Minor Histocompatibility Antigens, Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutamine addiction, as a hallmark of tumor metabolism, drives malignant progression via proliferation, survival, and metastasis. Alanine‐serine‐cysteine transporter 2 (ASCT2), the primary glutamine transporter, is overexpressed in tumors to meet metabolic demands, making it a promising therapeutic target. Accurately monitoring ASCT2‐mediated glutamine uptake is essential for investigating tumor metabolism and developing ASCT2‐targeted therapeutics. However, current methods lack specificity, require laborious sample processing, and do not support real‐time measurements in living systems. To overcome these issues, BLGLN is designed, an innovative bioluminescent reporter system exploiting Staudinger ligation. BLGLN comprises two components: 1) BL568, a caged D‐luciferin derivative protected with 2‐diphenylphosphinobenzoic acid, and 2) AA201, an azide‐modified glutamine mimetic taken up by ASCT2. Once inside, AA201 undergoes Staudinger ligation with membrane‐permeable BL568, releasing D‐luciferin that is converted by luciferase into a bioluminescent signal, allowing real‐time tracking of ASCT2‐dependent glutamine uptake in tumors. BLGLN provides simplified synthesis, eliminates complex sample preparation, and enables real‐time tracking and evaluation of glutamine uptake rate in living tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutamineAmino Acid Transport System ASCMinor Histocompatibility AntigensNeoplasmsLuminescent AgentsHumansAnimalsMiceCell Line, TumorLuminescent Measurements

Stichwörter der Autor:innen

ASCT2bioluminescent probeglutamine uptakereal‐time monitoring

Substanzen

GlutamineAmino Acid Transport System ASCMinor Histocompatibility AntigensSLC1A5 protein, humanLuminescent Agents

Autor:innen und Institutionen

  • School of Pharmacy, Hangzhou Normal University, Hangzhou, China.
  • Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, Hangzhou Normal University, Hangzhou, China.
  • Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, B. J., Zhao, J. L., Yin, F., Chen, W. D., Sun, Y., Ren, Y. Y., Chen, Y. M., Xie, T., Duan, C., & Zhou, J. L. (2025). Real‐Time Tracking of ASCT2‐Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe. Advanced Science. https://doi.org/10.1002/advs.202507057

Vancouver

Zhou BJ, Zhao JL, Yin F, Chen WD, Sun Y, Ren YY, et al. Real‐Time Tracking of ASCT2‐Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe. Advanced Science. 2025. doi:10.1002/advs.202507057

BibTeX
@article{Zhou2025,
  author = {Zhou, Bing-Jun and Zhao, Ji-Lei and Yin, Fan and Chen, Wen-Da and Sun, Yi and Ren, Ying-Ying and Chen, Yi-Min and Xie, Tian and Duan, Chong and Zhou, Jian-Liang},
  title = {Real‐Time Tracking of ASCT2‐Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202507057}
}
Kostenlos starten →